We are live on
!
Find out more
BG
Bellevue Group Portfolio holdings
AUM
$4.2B
1-Year Est. Return
54.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.16%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$5.86B
AUM Growth
+$4.04B
(+222%)
Cap. Flow
+$4.05B
Cap. Flow
% of AUM
69.18%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
220
New
83
Increased
86
Reduced
22
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$541M |
| 2 |
Incyte
INCY
|
+$293M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$290M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$228M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$28.3M |
| 2 |
Cencora
COR
|
+$19.9M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$16.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$14.7M |
| 5 |
Illumina
ILMN
|
+$9.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.72% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.42% |
| 4 | Financials | 0.06% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Mettler-Toledo International
MTD
$26.9B
| $399K | 0.01% |
+475
| New | +$358K |
|
|
CERN
152
DELISTED
Cerner Corp
CERN
| $388K | 0.01% |
+5,298
| New | +$357K |
|
|
VAR
153
DELISTED
Varian Medical Systems, Inc.
VAR
| $380K | 0.01% |
2,791
-16
| -0.6% | -$2.14K |
|
154
Kosmos Energy
KOS
$1.63B
| $376K | 0.01% |
+60,000
| New | +$383K |
|
|
AZPN
155
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $373K | 0.01% |
+3,000
| New | +$373K |
|
156
JD.com
JD
$40.6B
| $371K | 0.01% |
+12,263
| New | +$353K |
|
157
McCormick & Company Non-Voting
MKC
$13.5B
| $371K | 0.01% |
+4,782
| New | +$369K |
|
158
American Express
AXP
$233B
| $370K | 0.01% |
+3,000
| New | +$352K |
|
|
ANSS
159
DELISTED
Ansys
ANSS
| $369K | 0.01% |
+1,802
| New | +$343K |
|
160
Pool Corp
POOL
$6.68B
| $367K | 0.01% |
+1,921
| New | +$347K |
|
161
Broadridge
BR
$16.7B
| $365K | 0.01% |
+2,862
| New | +$345K |
|
162
Verisk Analytics
VRSK
$25.3B
| $365K | 0.01% |
+2,489
| New | +$351K |
|
163
VeriSign
VRSN
$23.8B
| $365K | 0.01% |
+1,744
| New | +$342K |
|
164
Moody's
MCO
$82.5B
| $363K | 0.01% |
+1,858
| New | +$353K |
|
165
Starbucks
SBUX
$118B
| $363K | 0.01% |
+4,334
| New | +$340K |
|
166
Domino's
DPZ
$10.7B
| $362K | 0.01% |
+1,300
| New | +$356K |
|
167
Trimble
TRMB
$11.7B
| $359K | 0.01% |
+7,958
| New | +$331K |
|
168
Brown-Forman Class B
BF.B
$11.8B
| $356K | 0.01% |
+6,417
| New | +$342K |
|
169
Adobe
ADBE
$84.3B
| $352K | 0.01% |
+1,193
| New | +$331K |
|
170
S&P Global
SPGI
$124B
| $352K | 0.01% |
+1,544
| New | +$337K |
|
171
Graco
GGG
$12.9B
| $346K | 0.01% |
+6,903
| New | +$348K |
|
|
CBPO
172
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $344K | 0.01% |
+3,609
| New | +$340K |
|
173
Blackbaud
BLKB
$1.44B
| $343K | 0.01% |
+4,107
| New | +$326K |
|
174
Huazhu Hotels Group
HTHT
$12.5B
| $339K | 0.01% |
+9,344
| New | +$349K |
|
175
Kirby Corp
KEX
$7.97B
| $338K | 0.01% |
+4,274
| New | +$343K |
|
Similar funds
WSFS
AC
HIP
DT
ATPW
BT
NCM
MSU
Bellevue Group's Q2 2019 Portfolio in Review
As of Q2 2019, Bellevue Group held 220 positions worth $5.86B, up 222% from $1.82B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Bellevue Group deployed $4.05B of net new capital in Q2 2019, opening 83 new positions and adding to 86 existing holdings. Its largest new stake was Agios Pharmaceuticals: 3,128,134 shares worth $156M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $28.3M trimmed.
- Bellevue Group's largest Q2 2019 buy was Agios Pharmaceuticals: 3,128,134 shares worth $156M.
- Bellevue Group added most to Ionis Pharmaceuticals in Q2 2019, an estimated $541M increase.
- Bellevue Group's biggest Q2 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $28.3M.
- Bellevue Group fully exited Cencora in Q2 2019, selling an estimated $19.9M.
- Bellevue Group's ten largest holdings make up 42% of its $5.86B portfolio in Q2 2019.
- Bellevue Group opened 83 new positions and closed 19 in Q2 2019.
- Bellevue Group's portfolio value rose 222% quarter-over-quarter to $5.86B.
Based on Bellevue Group's 13F filing for Q2 2019, filed 14 Aug 2019.